Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer: Results of a Compassionate Use Program in The Netherlands

CabazitaxelCompassionate Use ProgramMetastatic castrate-resistant prostate cancerTaxaneThe Netherlands